Who Paid My Doc
Research studies in the Open Payments record
139,921 studies have research funding reported against them. Being named on a study as a principal investigator is reported separately from being paid.
Studies
50 of 139,921- Lucitone In-Vitro Study No ClinicalTrials.gov identifier reported
- Lucy No ClinicalTrials.gov identifier reported
- Lum001 No ClinicalTrials.gov identifier reported
- Lum002 No ClinicalTrials.gov identifier reported
- Lum003 No ClinicalTrials.gov identifier reported
- Lum004 No ClinicalTrials.gov identifier reported
- Lum005 No ClinicalTrials.gov identifier reported
- Lumason Bolus vs Infusion No ClinicalTrials.gov identifier reported
- Lumason Bolus VS. Infusion: A Phase III Crossover Study to Evaluate Bolus Versus Continuous Infusion of Lumason in Patients With Sub-Optimal Unenhanced Echocardiography No ClinicalTrials.gov identifier reported
- Lumason Bolus VS. Infusion: A Phase III Crossover Study to Evaluate Bolus Versus Continuous Infusion of Lumason in Patients With Sub-Optimal Unenhanced Echocardiography ( No ClinicalTrials.gov identifier reported
- Lumateperone for the Improvement of Apathy in Patients with Psychotic Symptoms No ClinicalTrials.gov identifier reported
- Lumbar artery embolization in a swine model of lower back pain No ClinicalTrials.gov identifier reported
- Lumbar Fusion with 3D-Printed Porous Titanium Interbody Cages-A Single-Blinded Randomized Controlled Trial Evaluating Nexxt MatrixxTM Versus PEEK Cages NCT03647501
- LUMBAR SPINAL STENOSIS SURGERY hATTR PATIENT SCREEN No ClinicalTrials.gov identifier reported
- Lumbar Spine 20060326&20110142 CTscan AA No ClinicalTrials.gov identifier reported
- LUMC2017MR100Shea No ClinicalTrials.gov identifier reported
- Lumicitabine/hMPV project_Service Agreement - PR1165884 No ClinicalTrials.gov identifier reported
- LuMIERE: A Phase 1/2, Multicenter, Open-label, Non-randomized Study to Investigate Safety and Tolerability, Pharmacokinetics, Dosimetry, and Preliminary Activity of 177Lu-FAP-2286 in Patients With an Advanced Solid Tumor No ClinicalTrials.gov identifier reported
- LumiGuide Xperience Registry No ClinicalTrials.gov identifier reported
- Lumipulse in Vitro Study No ClinicalTrials.gov identifier reported
- Lumipulse Validation Studies No ClinicalTrials.gov identifier reported
- LUMI Retrospective No ClinicalTrials.gov identifier reported
- Lun 481 Phase II Study of Lorlatinib in Combination With Chemotherapy in Patients With Metastatic Anaplastic Lymphoma Kinase Positive Alk Nonsmall Cell Lung Cancer Nsclc Who Progressed on Singleagent Lorlatinib No ClinicalTrials.gov identifier reported
- Lun 481 Phase II Study of Lorlatinib in Combination With Chemotherapy in Patients With Metastatic Anaplastic Lymphoma Kinase Positive Alk Nonsmall Cell Lung Cancer Nsclc Who Progressed on Singleagent Lorlatinib No ClinicalTrials.gov identifier reported
- Luna No ClinicalTrials.gov identifier reported
- Luna Design Research No ClinicalTrials.gov identifier reported
- Luna, Karma No ClinicalTrials.gov identifier reported
- Luna,Karma No ClinicalTrials.gov identifier reported
- Lundy/St. Luke's Health/ Individualized Fluid Resuscitation in Hip Fracture Patients Using the Pleth Variability Index No ClinicalTrials.gov identifier reported
- Lundy/St. Luke's Health/ Individualized Fluid Resuscitation in Hip Fracture Patients Using the Pleth Variability Index No ClinicalTrials.gov identifier reported
- Lundy/St. Luke's Health/ Individualized Fluid Resuscitation in Hip Fracture Patients Using the Pleth Variability Index No ClinicalTrials.gov identifier reported
- Lundy/St. Luke's Health/ Individualized Fluid Resuscitation in Hip Fracture Patients Using the Pleth Variability Index No ClinicalTrials.gov identifier reported
- Lundy/St. Luke's Health/ Individualized Fluid Resuscitation in Hip Fracture Patients Using the Pleth Variability Index No ClinicalTrials.gov identifier reported
- Lung AI - GHL Study No ClinicalTrials.gov identifier reported
- Lung AI GHL Study No ClinicalTrials.gov identifier reported
- Lung Cancer Combo Study No ClinicalTrials.gov identifier reported
- Lung Cancer Early Detection - Panel/Algorithm Development for Indeterminate Pulmonary Nodule Maligna No ClinicalTrials.gov identifier reported
- Lung cancer early detection - Panel/algorithm development for indeterminate pulmonary nodule malignancy assessment No ClinicalTrials.gov identifier reported
- Lung cancer molecular profiling and clinical outcomes in US oncology community practices No ClinicalTrials.gov identifier reported
- Lung cancer molecular profiling and clinical outcomes in US oncology community practices. No ClinicalTrials.gov identifier reported
- Lung Cytomegalovirus CMV reactivation in Adults with Suspected Ventilator-Associated Pneumonia VAP No ClinicalTrials.gov identifier reported
- Lung function decline No ClinicalTrials.gov identifier reported
- Lung Function Improvement after Bronchoscopic Lung Volume Reduction with Pulmonx Endobronchial Valves used in Treatment of Emphysema No ClinicalTrials.gov identifier reported
- Lung GHL AI Study No ClinicalTrials.gov identifier reported
- Lung Guidance No ClinicalTrials.gov identifier reported
- LUNG-IST-127: A Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab (CP) for Patients With Metastatic sqNSCLC With Disease Control Following Induction Therapy No ClinicalTrials.gov identifier reported
- Lungmap No ClinicalTrials.gov identifier reported
- Lung MAP A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously Treated Non-Small Cell Lung Cancer Sub-Study S1900A A Phase II Study of Rucaparib in Patients with Genomic LOH High and/or Deleterious BRCA 1/2 Mutation Stage IV or Recurrent Non-Small Cell Lung Cancer No ClinicalTrials.gov identifier reported
- Lung MAP: A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously Treated Non-Small Cell Lung Cancer Sub-Study S1900A A Phase II Study of Rucaparib in Patients with Genomic LOH High and/or Deleterious BRCA 1/2 Mutation Stage IV or Recurrent Non-Small Cell Lung Cancer NCT03851445
- Lung Microbiome and Lung Metabolome in RA associat No ClinicalTrials.gov identifier reported